Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRK | VCYT |
|---|---|---|
| Price | $13.06 | $47.67 |
| Change today | ▲ 2.19% | ▲ 4.06% |
| Market cap | $3.83B | $3.83B |
| Return, 3 months | -7.9% | -15.1% |
| Return, year to date | -43.7% | +13.2% |
| Return, 1 year | -38.6% | +32.3% |
| P/E (TTM) | 7.3 | 34.1 |
| P/B | 1.5 | 2.8 |
| P/E percentile vs own 5y | 73rd | 71st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -25.2% | +15.5% |
| Net profit growth (YoY) | -88.5% | +2,701.0% |
| Gross margin | 12.1% | 72.2% |
| Operating margin | 6.0% | 15.3% |
| Net margin | 4.3% | 17.0% |
| Return on equity | – | – |
| Analyst target vs. price | +26.3% | +25.4% |
| Analyst buy share | 9% | 82% |
| RSI (14) | 45 | 59 |
| 30-day volatility | 53.9% | 60.6% |
| Max drawdown, 1 year | -55.0% | -39.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
